Cargando…
P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430163/ http://dx.doi.org/10.1097/01.HS9.0000847196.45811.7e |
| _version_ | 1784779677829693440 |
|---|---|
| author | Fiad, N. L. Prates, M. V. Fernandez, I. Kurgansky, N. Cerutti, A. Negri Aranguren, F. Guanchiale, L. Sackmann, F. Maradei, J. Enrico, A. Negri Aranguren, P. Pavlovsky, A. |
| author_facet | Fiad, N. L. Prates, M. V. Fernandez, I. Kurgansky, N. Cerutti, A. Negri Aranguren, F. Guanchiale, L. Sackmann, F. Maradei, J. Enrico, A. Negri Aranguren, P. Pavlovsky, A. |
| author_sort | Fiad, N. L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430163 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94301632022-08-31 P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA Fiad, N. L. Prates, M. V. Fernandez, I. Kurgansky, N. Cerutti, A. Negri Aranguren, F. Guanchiale, L. Sackmann, F. Maradei, J. Enrico, A. Negri Aranguren, P. Pavlovsky, A. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430163/ http://dx.doi.org/10.1097/01.HS9.0000847196.45811.7e Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Fiad, N. L. Prates, M. V. Fernandez, I. Kurgansky, N. Cerutti, A. Negri Aranguren, F. Guanchiale, L. Sackmann, F. Maradei, J. Enrico, A. Negri Aranguren, P. Pavlovsky, A. P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA |
| title | P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA |
| title_full | P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA |
| title_fullStr | P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA |
| title_full_unstemmed | P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA |
| title_short | P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA |
| title_sort | p1082: safety and efficacy analysis in older patients treated within the gatla lh-05 protocol: pet-adapted therapy after 3 cycles of abvd for all stages of hodgkin lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430163/ http://dx.doi.org/10.1097/01.HS9.0000847196.45811.7e |
| work_keys_str_mv | AT fiadnl p1082safetyandefficacyanalysisinolderpatientstreatedwithinthegatlalh05protocolpetadaptedtherapyafter3cyclesofabvdforallstagesofhodgkinlymphoma AT pratesmv p1082safetyandefficacyanalysisinolderpatientstreatedwithinthegatlalh05protocolpetadaptedtherapyafter3cyclesofabvdforallstagesofhodgkinlymphoma AT fernandezi p1082safetyandefficacyanalysisinolderpatientstreatedwithinthegatlalh05protocolpetadaptedtherapyafter3cyclesofabvdforallstagesofhodgkinlymphoma AT kurganskyn p1082safetyandefficacyanalysisinolderpatientstreatedwithinthegatlalh05protocolpetadaptedtherapyafter3cyclesofabvdforallstagesofhodgkinlymphoma AT ceruttia p1082safetyandefficacyanalysisinolderpatientstreatedwithinthegatlalh05protocolpetadaptedtherapyafter3cyclesofabvdforallstagesofhodgkinlymphoma AT negriarangurenf p1082safetyandefficacyanalysisinolderpatientstreatedwithinthegatlalh05protocolpetadaptedtherapyafter3cyclesofabvdforallstagesofhodgkinlymphoma AT guanchialel p1082safetyandefficacyanalysisinolderpatientstreatedwithinthegatlalh05protocolpetadaptedtherapyafter3cyclesofabvdforallstagesofhodgkinlymphoma AT sackmannf p1082safetyandefficacyanalysisinolderpatientstreatedwithinthegatlalh05protocolpetadaptedtherapyafter3cyclesofabvdforallstagesofhodgkinlymphoma AT maradeij p1082safetyandefficacyanalysisinolderpatientstreatedwithinthegatlalh05protocolpetadaptedtherapyafter3cyclesofabvdforallstagesofhodgkinlymphoma AT enricoa p1082safetyandefficacyanalysisinolderpatientstreatedwithinthegatlalh05protocolpetadaptedtherapyafter3cyclesofabvdforallstagesofhodgkinlymphoma AT negriarangurenp p1082safetyandefficacyanalysisinolderpatientstreatedwithinthegatlalh05protocolpetadaptedtherapyafter3cyclesofabvdforallstagesofhodgkinlymphoma AT pavlovskya p1082safetyandefficacyanalysisinolderpatientstreatedwithinthegatlalh05protocolpetadaptedtherapyafter3cyclesofabvdforallstagesofhodgkinlymphoma |